Serum Β 2-Microglobulin in Myelomatosis: Potential Value in Stratification and Monitoring

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1980.273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evaluation of Serum Β 2-Microglobulin as a Prognostic Indicator in Myelomatosis

British Journal of Cancer
Cancer ResearchOncology
1983English

Serum .BETA.2-microglobulin in Chronic Liver Diseases.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1981English

"Myeloma" Serum Electrophoretic Patterns in Conditions Other Than Myelomatosis

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1959English

The Association of Serum hsCRP and Urinary Alpha1-Microglobulin in Patients With Type 2 Diabetes Mellitus

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Estimation of Serum Beta 2- Microglobulin Among Newly Diagnosed Children With Cancer in Basra

Journal of Radiology and Oncology
2018English

Structure of the Preamyloid Dimer of Β-2-Microglobulin From Covalent Labeling and Mass Spectrometry

Biochemistry
Biochemistry
2010English

Clinical Significance of Serum and Urinary Β2-Microglobulin

RADIOISOTOPES
1977English

Nuclear Magnetic Resonance Measured Serum Biomarkers and Type 2 Diabetes Risk Stratification

Journal of Diabetes, Metabolic Disorders & Control
2015English

Haemolytic Anaemia in Myelomatosis

Postgraduate Medical Journal
Medicine
1973English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy